Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Zoledronic Acid × Clear all

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00083382 2015-06-24

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Phase 2 Completed

83 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell